Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class ASSE: 600332

Announcement on Subsidiary’s Drug Entering Phase III Clinical Trials

· Issued by Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class A via Shanghai Stock Exchange
Announcement on Subsidiary’s Drug Entering Phase III Clinical Trials

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Company analysis